血型檢測市場規模、佔有率及成長分析（按產品、檢測類型、方法、技術、應用、最終用戶和地區）－產業預測（2025-2032）

2023 年全球血型檢測市場規模為 18.9 億美元，預計將從 2024 年的 20.6 億美元成長到 2032 年的 41.4 億美元，預測期內（2025-2032 年）的複合年成長率為 9.1%。

全球血型檢測市場受技術進步、輸血需求成長以及活性化意識宣傳活動的推動。癌症和貧血等需要頻繁輸血的慢性疾病的流行，大大增加了對準確血型檢測的需求。 PCR、微陣列和大規模平行定定序等創新技術正在提高血型檢測過程的效率和準確性。此外，已開發市場和新興市場醫療設施的擴張也進一步推動了該服務的需求。然而，高成本、基礎設施不足以及倫理問題等挑戰可能會阻礙市場在2032年之前的成長。人工智慧和自動化在血型檢測中的持續整合，是提高診斷準確性和周轉時間的有效途徑。

目錄

介紹

• 分析目的
• 市場覆蓋
• 定義

分析方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況與展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場觀察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• Start-Ups分析

全球血型檢測市場規模及複合年成長率（按產品及服務分類）（2025-2032 年）

• 市場概覽
• 耗材
  • 抗血清試劑
  • 抗人類球蛋白試劑
  • 紅血球試劑
  • 血庫生理食鹽水
• 裝置
• 服務和軟體

全球血型檢測市場規模及依檢測類型分類的複合年成長率（2025-2032）

• 市場概覽
• ABO 血型檢測/Rh 血型檢測
• 抗體篩檢
• HLA型檢測
• 交叉配對試驗
• 依抗原類型

全球血型檢測市場規模及複合年成長率（依方法分類）（2025 年至 2032 年）

• 市場概覽
• 基於分析的技術
• 基於PCR和微陣列技術
• 大規模平行定序
• 其他方法

全球血型檢測市場規模及複合年成長率（依技術分類）（2025-2032）

• 市場概覽
• 分子類型分類
• 血清分型
• 基於微陣列的測定
• 次世代定序

全球血型分析市場規模及複合年成長率（按應用分類）（2025-2032）

• 市場概覽
• 輸血
• 器官移植
• 診斷測試

全球血型檢測市場規模及最終用戶複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 血庫
• 臨床實驗室
• 其他最終用戶

全球血型市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Bio-Rad Laboratories, Inc.（United States）
• Ortho Clinical Diagnostics（United States）
• Quotient Limited（Switzerland）
• Immucor, Inc.（United States）
• Grifols SA（Spain）
• Bio-Techne Corporation（United States）
• DIAGAST（France）
• Tulip Diagnostics（India）
• AXO Science（France）
• Beckman Coulter, Inc.（United States）
• MTC Invitro Diagnostics（Germany）
• BAG Diagnostics GmbH（Germany）
• Rapid Labs Ltd.（United Kingdom）
• NG Biotech（France）
• Demeditec Diagnostics GmbH（Germany）
• Sero AS（Norway）
• Alcor Scientific Inc.（United States）
• Tulip Group（India）
• Medion Grifols Diagnostics AG（Switzerland）

結論和建議

Global Blood Group Typing Market size was valued at USD 1.89 billion in 2023 and is poised to grow from USD 2.06 billion in 2024 to USD 4.14 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global blood group typing market is being propelled by technological advancements, rising demand for blood transfusions, and increasing awareness initiatives. The prevalence of chronic diseases like cancer and anemia, which necessitate frequent transfusions, is significantly boosting the need for accurate blood typing. Innovative techniques such as PCR, microarray, and massively parallel sequencing are enhancing the efficiency and accuracy of blood typing processes. Additionally, the expansion of healthcare facilities across both developed and emerging markets is further driving service demand. However, challenges such as high costs, inadequate infrastructure, and ethical concerns may hinder market growth through 2032. The ongoing integration of AI and automation in blood typing holds promise for improving diagnostic precision and turnaround times moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Group Typing Market Segments Analysis

Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Group Typing Market

Globally, governments are enacting policies and programs aimed at encouraging blood donation and enhancing the safety of blood transfusions. Such initiatives play a crucial role in improving the outlook of the blood group typing market by raising awareness and making blood typing services more accessible. Moreover, public health campaigns and subsidies for blood typing equipment are facilitating healthcare facilities' adoption of modern blood typing technologies. As a result, the market is poised for growth as these supportive measures continue to foster a culture of safety and accessibility in blood donation and transfusion practices worldwide.

Restraints in the Global Blood Group Typing Market

A notable restraint in the Global Blood Group Typing market is the variability in test results and the challenges associated with ensuring consistent accuracy. Inconsistencies can arise from various factors, including variations in testing methodologies, quality of reagents, and the skill level of operators. Such discrepancies not only compromise patient safety but also undermine the reliability of blood typing procedures. This inconsistency poses a significant barrier to the widespread adoption of blood group typing solutions and services, potentially limiting their growth and acceptance in the healthcare sector in the years to come.

Market Trends of the Global Blood Group Typing Market

The Global Blood Group Typing market is witnessing a significant shift towards molecular typing techniques, moving away from traditional serological methods. Advanced technologies such as PCR and DNA sequencing are gaining popularity for their precision in identifying rare and weak blood group antigens, making them invaluable in complex scenarios like prenatal testing and in patients with multiple transfusions. This transition not only enhances the accuracy of blood typing but also minimizes risks of alloimmunization and transfusion reactions, positioning these molecular methods as critical components for improved patient outcomes. Consequently, this trend is poised to substantially increase revenue generation potential in the blood typing industry throughout the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Startup Analysis

Global Blood Group Typing Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Consumables
  • Antisera Reagents
  • Anti-human Globulin Reagents
  • Red Blood Cell Reagents
  • Blood Bank Saline
• Instruments
• Services & Software

Global Blood Group Typing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• ABO Blood Tests & Rh Typing
• Antibody Screening
• HLA Typing
• Cross-matching Tests
• Antigen Typing

Global Blood Group Typing Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Assay-based Techniques
• PCR-based and Microarray Techniques
• Massively Parallel Sequencing
• Other Techniques

Global Blood Group Typing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Molecular Typing
• Serological Typing
• Microarray-based Typing
• Next-generation Sequencing

Global Blood Group Typing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Blood transfusions
• Organ transplants
• Diagnostic testing

Global Blood Group Typing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Blood Banks
• Clinical Laboratories
• Other End Users

Global Blood Group Typing Market Size & CAGR (2025-2032)

• North America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Technique, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Technique, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIAGAST (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXO Science (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTC Invitro Diagnostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Labs Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NG Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Demeditec Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sero AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcor Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medion Grifols Diagnostics AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations